Bart Barlogie, M.D., Ph.D.
Director of the UAMS Myeloma Insititute
Multiple myeloma, a type of cancer that affects the plasma cells, is an incurable but treatable disease. Nationwide, the median survival rate of patients with multiple myeloma is only about four years. But at our UAMS Myeloma Institute for Research and Therapy, the survival rate is closer to eight or nine years. Five-year survival rates at the Myeloma Institute are greater than 65% — nearly twice the average of any other treatment facility.
The UAMS Myeloma Institute is one of the largest centers in the world for research and clinical care related to myeloma and related disorders. Our institute has accomplished many feats under the leadership of Dr. Bart Barlogie, who is internationally recognized for his work on myeloma. We were the first to:
- Use tandem bone marrow/peripheral blood stem cell transplants
- Perform transplants on an outpatient basis
- Safely transplant patients age 70 and above
- Introduce thalidomide as anti-angiogenesis therapy
Our success in treating multiple myeloma patients is based on the findings of our research program. UAMS offers comfort to patients through the personalized treatment plans provided by our caring and compassionate medical staff.
Myeloma is the second most common blood cancer, but it is not a common cancer. This type of cancer is predominately found in older people; more than 80% of people with myeloma are 60 years old or older. Some of the symptoms of the cancer are:
- Bone pain
- Infection (common infections like pneumonia)
- Renal failure
- Neurological symptoms (common problems are weakness, confusion and fatigue)
The UAMS Myeloma Institute sees more patients with myeloma and related diseases per year than any other institution in the world. On any given day, there are more than 200 myeloma patients staying in Little Rock for diagnosis and treatment. When dealing with a disease that currently is incurable, UAMS can offer hope to you and your family.
Learn more about the UAMS Myeloma Institute for Research and Therapy.
To make an appointment, contact the Myeloma Institute:
Toll Free: 1-888-MYELOMA